Stocks · Korea 063160 KOSPI

CKD Bio

15,070원 +11.46% Market cap 827억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR0.65x
EPS0 KRW
BPS23,156 KRW
ROE-4.65%
DPS0 KRW

Returns and 52-week range

1W+15.04%
1M+10.81%
3M+11.55%
6M-21.67%
1Y-38.49%
YTD-25.95%
52W high24,900원
52W low11,770원
From 52W high-39.48%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20211,422억-114억-66억-8.0%
20221,560억-148억-167억-9.5%
Quarterly
2022 2Q367억-40억-49억-10.8%
2022 3Q376억-6억-35억-1.7%
2022 4Q349억-99억-71억-28.4%
2023 1Q437억-36억-29억-8.3%
2023 2Q390억-58억-68억-15.0%
2023 3Q423억-57억-64억-13.4%

Company

CEO박완갑
Founded2001-11-12
Fiscal year end12
Address: 서울특별시 서대문구 충정로 8

Peers in the same sector

CompanyMarket capP/EP/B1M
CMG제약832억—0.41-9.79%
수젠텍819억—0.98+12.40%
엔지켐생명과학838억—0.54+0.00%
삼익제약815억—1.08+42.86%
셀루메드840억—6.59+0.00%
폴라리스AI파마789억12.800.58+11.44%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.